Fundraising Fox
Delphian Therapeutics
1 known investors
Find your way into Delphian Therapeutics
Sign up to see every warm intro you have to Delphian Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Delphian Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Delphian Tx is a clinical-stage biopharmaceutical company developing cannabinoid-based drugs (CBD:THC combinations) targeting the endocannabinoid system to treat migraine and other complex pain and CNS disorders. The company has a Phase 1 clinical trial ongoing and issued USPTO patents.
Investors · 1
Frequently asked questions
- What does Delphian Therapeutics do?
- Delphian Tx is a clinical-stage biopharmaceutical company developing cannabinoid-based drugs (CBD:THC combinations) targeting the endocannabinoid system to treat migraine and other complex pain and CNS disorders. The company has a Phase 1 clinical trial ongoing and issued USPTO patents.
- Who are Delphian Therapeutics's investors?
- Delphian Therapeutics's investors include 2Flo Ventures.